Eisai
4523.T
#2228
Rank
ยฃ6.60 B
Marketcap
ยฃ23.42
Share price
-0.46%
Change (1 day)
-10.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): ยฃ0.67

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ0.65. In 2026 the company made an earnings per share (EPS) of ยฃ0.65 a decrease over its 2025 EPS that were of ยฃ0.82.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026ยฃ0.65-21.04%
2025ยฃ0.8211.85%
2024ยฃ0.73-32.63%
2023ยฃ1.085.52%
2022ยฃ1.03-74.01%
2021ยฃ3.95-66.58%
2020ยฃ11.8398.24%
2019ยฃ5.9717.01%
2018ยฃ5.1037.78%
2017ยฃ3.70-27.62%
2016ยฃ5.1135.33%
2015ยฃ3.78-2.82%
2014ยฃ3.89-27.66%
2013ยฃ5.37-27.49%
2012ยฃ7.41-12.67%
2011ยฃ8.4988.08%
2010ยฃ4.51-11.06%
2009ยฃ5.07-390.15%
2008-ยฃ1.75-127.78%
2007ยฃ6.30347.11%
2006ยฃ1.414.38%
2005ยฃ1.357.4%
2004ยฃ1.2643.03%
2003ยฃ0.8825.09%
2002ยฃ0.7052.67%
2001ยฃ0.4669.76%
2000ยฃ0.27